Edwards Lifesciences Aktie

Kaufen
Verkaufen
65,68 EUR -1,35 EUR -2,01 %
70,20 USD +0,29 USD +0,41 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 37,73 Mrd. EUR

KGV 33,13 Div. Rendite 0,00%

WKN 936853

ISIN US28176E1082

Symbol EW


Edwards Lifesciences Aktie Analyse

12.12.11 Edwards Lifesciences buy Citigroup Corp.
14.10.11 Edwards Lifesciences outperform RBC Capital Markets
24.08.11 Edwards Lifesciences outperform Morgan Keegan & Co., Inc.
10.08.11 Edwards Lifesciences buy Goldman Sachs Group Inc.
25.07.11 Edwards Lifesciences outperform Morgan Keegan & Co., Inc.
31.05.11 Edwards Lifesciences outperform RBC Capital Markets
21.04.11 Edwards Lifesciences neutral Wedbush Morgan Securities Inc.
12.04.11 Edwards Lifesciences overweight Barclays Capital
30.03.11 Edwards Lifesciences hold Jefferies & Company Inc.
15.12.10 Edwards Lifesciences buy UBS AG
15.12.10 Edwards Lifesciences overweight Barclays Capital
27.10.10 Edwards Lifesciences overweight Barclays Capital
06.10.10 Edwards Lifesciences overweight Barclays Capital
27.09.10 Edwards Lifesciences neutral Goldman Sachs Group Inc.
24.09.10 Edwards Lifesciences outperform RBC Capital Markets
24.09.10 Edwards Lifesciences overweight Barclays Capital
24.09.10 Edwards Lifesciences overweight Piper Jaffray & Co.
22.07.10 Edwards Lifesciences outperform RBC Capital Markets
12.07.10 Edwards Lifesciences kaufen William Blair
24.06.10 Edwards Lifesciences halten Goldman Sachs Group Inc.
22.04.10 Edwards Lifesciences kaufen Goldman Sachs Group Inc.
21.04.10 Edwards Lifesciences halten Caris & Company, Inc.
12.04.10 Edwards Lifesciences verkaufen Wedbush Morgan Securities Inc.
11.12.09 Edwards Lifesciences outperform Credit Suisse Group
17.11.09 Edwards Lifesciences overweight Barclays Capital
29.10.09 Edwards Lifesciences buy Goldman Sachs Group Inc.
22.10.09 Edwards Lifesciences neutral Wedbush Morgan Securities Inc.
25.09.09 Edwards Lifesciences buy UBS AG
01.09.09 Edwards Lifesciences outperform Credit Suisse Group
28.07.09 Edwards Lifesciences underperform Wedbush Morgan Securities Inc.
22.07.09 Edwards Lifesciences outperform Credit Suisse Group
01.07.09 Edwards Lifesciences neutral UBS AG
12.06.09 Edwards Lifesciences neutral Robert W. Baird & Co. Incorporated
26.02.09 Edwards Lifesciences outperform RBC Capital Markets
24.02.09 Edwards Lifesciences outperform Credit Suisse Group
07.11.08 Edwards Lifesciences buy Piper Jaffray & Co.
24.07.08 Edwards Lifesciences buy Stanford Financial Group, Inc.
10.06.08 Edwards Lifesciences outperform Credit Suisse Group
05.06.08 Edwards Lifesciences buy Stanford Financial Group, Inc.
20.05.08 Edwards Lifesciences outperform Credit Suisse Group
24.04.08 Edwards Lifesciences buy Stanford Financial Group, Inc.
24.04.08 Edwards Lifesciences outperform Credit Suisse Group
18.03.08 Edwards Lifesciences buy Stanford Financial Group, Inc.
28.01.08 Edwards Lifesciences neutral Cowen and Company, LLC
10.12.07 Edwards Lifesciences outperform Credit Suisse Group
05.10.07 Edwards Lifesciences outperform Piper Jaffray & Co.
30.04.07 Edwards Lifesciences buy Needham & Co
09.03.07 Edwards Lifesciences underweight Morgan Stanley
01.03.07 Edwards Lifesciences average Caris & Company
06.02.07 Edwards Lifesciences Market Perform Piper Jaffray